Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christophe Richez

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
RMD Open|September 23, 2024
Anifrolumab: the new frontier in the treatment of genetic interferonopathiesMarie-Louise Frémond, Clémence David, Christophe Richez
Joint Bone Spine|December 4, 2019
Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheetsChristophe Richez, Jacques Morel, Jean Sibilia, et al.
Joint Bone Spine|March 26, 2018
Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)Thierry Schaeverbeke, Thao Pham, Christophe Richez, et al.
Joint Bone Spine|June 9, 2016
A unilateral erosive arthritis in a patient with systemic lupus erythematosusMarc Scherlinger, Thierry Schaeverbeke, Patrick Blanco, et al.
Expert Review of Clinical Immunology|October 6, 2023
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosusNoémie Gensous, Estibaliz Lazaro, Patrick Blanco, et al.
Expert Opinion on Investigational Drugs|August 1, 2014
Atacicept as an investigated therapy for rheumatoid arthritisChristophe Richez, Marie-Elise Truchetet, Thierry Schaeverbeke, et al.
Joint Bone Spine|June 29, 2021
Practical management of patients on anti-IL6R therapy - the CRI guidelinesJacques Morel, Anne Tournadre, Jérémie Sellam, et al.
Joint Bone Spine|May 16, 2021
Practical management of patients on anti-TNF therapy - the CRI guidelinesJérémie Sellam, Jacques Morel, Anne Tournadre, et al.
Joint Bone Spine|November 13, 2012
Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexateAudrey Pierreisnard, Nahema Issa, Thomas Barnetche, et al.
Expert Review of Clinical Pharmacology|October 9, 2025
Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosusMayalen Uthurriague, Estibaliz Lazaro, Christophe Richez, et al.
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
RMD Open|September 23, 2024
Anifrolumab: the new frontier in the treatment of genetic interferonopathiesMarie-Louise Frémond, Clémence David, Christophe Richez
Joint Bone Spine|December 4, 2019
Practical management of patients on Janus kinase inhibitor (JAKi) therapy - the CRI fact sheetsChristophe Richez, Jacques Morel, Jean Sibilia, et al.
Joint Bone Spine|March 26, 2018
Biosimilars: An opportunity. Position statement of the French Rheumatology Society (SFR) and Inflammatory Rheumatic Disease Club (CRI)Thierry Schaeverbeke, Thao Pham, Christophe Richez, et al.
Joint Bone Spine|June 9, 2016
A unilateral erosive arthritis in a patient with systemic lupus erythematosusMarc Scherlinger, Thierry Schaeverbeke, Patrick Blanco, et al.
Expert Review of Clinical Immunology|October 6, 2023
Anifrolumab: first biologic approved in the EU not restricted to patients with a high degree of disease activity for the treatment of moderate to severe systemic lupus erythematosusNoémie Gensous, Estibaliz Lazaro, Patrick Blanco, et al.
Expert Opinion on Investigational Drugs|August 1, 2014
Atacicept as an investigated therapy for rheumatoid arthritisChristophe Richez, Marie-Elise Truchetet, Thierry Schaeverbeke, et al.
Joint Bone Spine|June 29, 2021
Practical management of patients on anti-IL6R therapy - the CRI guidelinesJacques Morel, Anne Tournadre, Jérémie Sellam, et al.
Joint Bone Spine|May 16, 2021
Practical management of patients on anti-TNF therapy - the CRI guidelinesJérémie Sellam, Jacques Morel, Anne Tournadre, et al.
Joint Bone Spine|November 13, 2012
Meta-analysis of clinical and radiological efficacy of biologics in rheumatoid arthritis patients naive or inadequately responsive to methotrexateAudrey Pierreisnard, Nahema Issa, Thomas Barnetche, et al.
Expert Review of Clinical Pharmacology|October 9, 2025
Pharmacology considerations for managing pregnancy in women with systemic lupus erythematosusMayalen Uthurriague, Estibaliz Lazaro, Christophe Richez, et al.
Pageof 21